-
NEWS
BD Reports First Quarter Fiscal 2025 Financial ResultsLearn MoreCompany Delivers Revenue, Margin and Earnings Ahead of its Expectations Revenue of $5.2 billion increased 9.8% as reported, 9.6% currency-neutral and 3.9% organic GAAP and adjusted diluted EPS of...
-
NEWS
BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock ValueLearn MoreCompelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation "New BD," built on momentum of BD...
-
BLOG
How AMR impacts vulnerable populationsAction is needed to slow drug-resistant infections in vulnerable populations.Learn More